Tag Archives: Adult

FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia in Adult Patients

FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia in Adult Patients Print this page December 23, 2019 — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) today announced that the U.S. Food and Drug Administration (FDA) approved the new drug application for its in-house discovered and developed orexin receptor antagonist Dayvigo (lemborexant). Dayvigo… Read More »

Adult Foot Health

The American Orthopaedic Foot & Ankle Society (AOFAS) offers information on this site as an educational service. The content of FootCareMD, including text, images, and graphics, is for informational purposes only. The content is not intended to substitute for professional medical advice, diagnoses or treatments. If you need medical advice, use the “Find a Surgeon”… Read More »

Adult acne: Understanding underlying causes and banishing breakouts – Harvard Health Blog – Harvard Health

“I’m not a teenager anymore, why do I still have acne?!” This is a question we hear from patients on a daily basis. The truth is, it is quite common to see acne persist into adulthood. Although acne is commonly thought of as a problem of adolescence, it can occur in people of all ages.… Read More »

10 Early Signs of Alzheimer’s Every Adult Should Know

Conditions If you or a loved one experiences these subtle but possibly serious symptoms of memory loss, confusion, sleeplessness, and trouble focusing, talk to a doctor. Why early detection matters mrmohock/Shutterstock With grim prognoses and very limited treatments for Alzheimer’s disease, early detection hasn’t been particularly advantageous. But that may be changing—fast. One of the… Read More »

Adult Acne Is On The Rise — & It Goes Way Beyond Surface Level – Refinery29

“While teenagers are vulnerable to depression and anxiety stemming from the condition at this developmental stage, studies show that as a group, it’s the adult population that experiences it the most,” says Keira Barr, MD, a board-certified dermatologist whose practice, the Resilient Health Institute, is dedicated to what she calls the “intimate and intricate brain-skin… Read More »

FDA Approves Broadened Indication for Xeomin (incobotulinumtoxinA) as First-Line Treatment for Blepharospasm (Involuntary Blinking) in Adult Patients

Print this page RALEIGH, N.C.  –  May 13,  2019  –  Merz Americas announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Xeomin (incobotulinumtoxinA), broadening its indication to be a first-line treatment of blepharospasm (involuntary blinking) in adult patients. “Merz is proud to offer a first-line… Read More »